Department of Biochemistry, College of Medicine, University of Vermont, Burlington, VT 05446, USA.
Thromb Res. 2010 Aug;126(2):119-23. doi: 10.1016/j.thromres.2010.04.004. Epub 2010 May 7.
The quantitation of factor (F)VIII by activity-based assays is influenced by the method, procedure, the quality and properties of reagents used and concentrations of other plasma proteins, including von Willebrand factor (VWF).
To compare FVIII concentrations measured by activity-based assays with those obtained by an immunoassay and to establish the influence of plasma dilution on the FVIII clotting activity (FVIIIc).
The APTT, a chromogenic assay (Coatest) and two in-house immunoassays were used. Albumin-free recombinant FVIII was used as the calibrator in all assays.
For a group of 44 healthy individuals (HI), the mean value observed for FVIII antigen (FVIIIag; 1.22+/-0.56 nM; S.D.) is substantially higher than that for FVIIIc (0.65+/-0.29 nM) and the chromogenic assay (FVIIIch; 0.50+/-0.23 nM). A positive correlation between FVIIIag and VWFag with R(2)=0.20 was observed. Since plasma VWF has an inhibitory effect on FVIIIc, we evaluated the influence of plasma dilutions on FVIIIc in HI (n=105). At a 4-fold dilution, estimates of FVIIIc by clotting assay were much lower than FVIIIag (0.77+/-0.31 vs. 1.14+/-0.48 nM). At 10- and 25-fold dilutions, the estimated FVIIIc increased to 0.87+/-0.36 and 0.94+/-0.44 nM, respectively.
基于活性的测定因子(F)VIII 的定量受到方法、程序、所用试剂的质量和特性以及其他血浆蛋白(包括血管性血友病因子(VWF))的浓度的影响。
比较基于活性的测定法测定的 FVIII 浓度与免疫测定法获得的 FVIII 浓度,并确定血浆稀释对 FVIII 凝血活性(FVIIIc)的影响。
使用 APTT、显色测定法(Coatest)和两种内部免疫测定法。所有测定均使用无白蛋白重组 FVIII 作为校准物。
在一组 44 名健康个体(HI)中,FVIII 抗原(FVIIIag;1.22±0.56 nM;S.D.)的平均值明显高于 FVIIIc(0.65±0.29 nM)和显色测定法(FVIIIch;0.50±0.23 nM)。观察到 FVIIIag 与 VWFag 之间存在正相关,R(2)=0.20。由于血浆 VWF 对 FVIIIc 具有抑制作用,我们评估了 HI(n=105)中血浆稀释对 FVIIIc 的影响。在 4 倍稀释时,凝血测定法估计的 FVIIIc 明显低于 FVIIIag(0.77±0.31 对 1.14±0.48 nM)。在 10 倍和 25 倍稀释时,估计的 FVIIIc 分别增加至 0.87±0.36 和 0.94±0.44 nM。
1)在血浆中,FVIIIag 高于 FVIIIc 和 FVIIIch;2)通过测量 FVIIIag 可以估计血浆中的真实 FVIII 浓度。